Elixir Therapeutics Private Limited - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2006.
2006 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Elixir Therapeutics Private Limited

Elixir Therapeutics Private Limited, a struck off private limited company, was established on 02 March 2006 in Hyderabad, Telangana, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239TG2006PTC049366. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bikshapathi Naik Korra (Additional Director), Nirmala Gandluri (Additional Director), Peddi Jagadishwar (Managing Director). Past directors included Kotha Bhusura Venkata Subramanya Prasad, Vagicherla Subramanyam, Vallabadas Satyanarayana Goud. Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at 1-48/2 Street No 2 Venkateswara Colony Uppal, Hyderabad, Telangana, 500039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2006PTC049366

  • Registration Number

    049366

  • Incorporation Date

    02 March 2006

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 19 Year, 11 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Elixir Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elixir Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Elixir Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Bikshapathi Naik Korra Additional Director 14 Sep 2012 Current
Nirmala Gandluri Additional Director 04 Apr 2012 Current
Peddi Jagadishwar Managing Director 02 Mar 2006 Current
Jyothi Sandrapalli Additional Director 04 Apr 2012 Current
Naresh Kumar Peddi Additional Director 04 Apr 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Jan 2008 Past
Pramod Abcsdd Director 14 Sep 2012 Past
Pramod Abcsdd Director 24 Jan 2008 Past
Pramod Abcsdd Managing Director 05 Mar 2006 Past
Pramod Abcsdd Director 24 Jan 2008 Past
Pramod Abcsdd Director 14 Sep 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elixir Therapeutics.

Enhance accessibility to Elixir Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Elixir Therapeutics revenue growth over time
Elixir Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elixir Therapeutics?

Unlock access to Elixir Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Elixir Therapeutics?

Unlock and access historical data on people associated with Elixir Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elixir Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixir Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elixir Therapeutics
Recent Activity within the Organization
  • Director Appointment

    Progress on Bikshapathi Naik Korra was appointed as a Additional Director was appointed as a Additional Director on 14 Sep 2012 & has been associated with this company since 13 years 5 months . was documented.

  • Director Appointment

    The activity Nirmala Gandluri was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2012 & has been associated with this company since 13 years 10 months . was completed.

  • Director Appointment

    Jyothi Sandrapalli was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2012 & has been associated with this company since 13 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Naresh Kumar Peddi was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2012 & has been associated with this company since 13 years 10 months . was completed.

  • Annual General Meeting

    Elixir Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Elixir Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Hyderabad. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elixir Therapeutics Private Limited?

The CIN of Elixir Therapeutics Private Limited is U24239TG2006PTC049366.

Where is Elixir Therapeutics Private Limited headquartered?

Elixir Therapeutics Private Limited is headquartered at 1-48/2 Street No 2 Venkateswara Colony Uppal, Hyderabad, Telangana, 500039.

When was Elixir Therapeutics Private Limited incorporated?

Elixir Therapeutics Private Limited was incorporated on 02 March 2006.

Who are the current directors of Elixir Therapeutics Private Limited?

The current directors of Elixir Therapeutics Private Limited are

What is the primary industry of Elixir Therapeutics Private Limited?

The primary industry of Elixir Therapeutics Private Limited is Chemicals.

Is Elixir Therapeutics Private Limited a listed company?

Elixir Therapeutics Private Limited is unlisted.

What is the capital structure of Elixir Therapeutics Private Limited?

The authorized capital of Elixir Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available